Our editorial standard
- Primary guidelines, regulatory documents and peer-reviewed clinical trials are prioritized.
- Every time-sensitive page displays a medical review date and a planned review date.
- Regulatory approval in one country is not presented as approval in Pakistan.
- Trial averages are not converted into promises for individual patients.
- Uncertainty, important limitations and conflicts of interest are stated where relevant.
- Content is written originally for patients and referring clinicians; it is not copied from manufacturers.
Educational content supports—not replaces—an individual consultation. New or worsening symptoms, medicine changes and urgent concerns require appropriate clinical assessment.